Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Astrazeneca Ord Shs AZNCF

Healthcare
AstraZeneca PLC is a science-led biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza... see more

Recent & Breaking News (OTCPK:AZNCF)

Providing Quality Healthcare Through Long-term Investments, Divestitures, New Research, Clinical Trials Results - Research Report on AmerisourceBergen, Zoetis, AstraZeneca, Cardinal Health and Sanofi

PR Newswire June 12, 2013

SumTotal Customers and Industry Leaders Kick off Talent Expansion(TM) Tour 2013

Business Wire June 11, 2013

GSK, AZN, KERX, and RPTP Early Briefing and Review

Accesswire June 7, 2013

A New Approach to Treating Cancer

Accesswire June 5, 2013

OMTHERA PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors of Claims of Breaches of Fiduciary Duty by Board of Omthera Pharmaceuticals, Inc. in Connection With Sale of Company -- OMTH

Globe Newswire June 4, 2013

Customers Vote SumTotal Finalist in Four Best of Elearning! 2013 Awards

Business Wire June 4, 2013

U.S. FDA Grants Priority Review to Bristol-Myers Squibb and AstraZeneca's Metreleptin, an Investigational Agent for Treatment of Metabolic Disorders Associated with Rare Forms of Lipodystrophy

Business Wire June 4, 2013

Olaparib in Patients With BRCA Mutated Platinum-Sensitive Relapsed Serous Ovarian Cancer: New Data Presented at ASCO

Business Wire June 1, 2013

OMTHERA PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty by Board of Omthera Pharmaceuticals, Inc. in Connection with Sale of Company to AstraZeneca Plc

PR Newswire May 30, 2013

Adult Patients in England and Wales to Gain Access to First-in-Class Type 2 Diabetes Treatment

PR Newswire May 29, 2013

Free Research Reports on ARCP, AZN, FE and SWSH Issued by the Bedford Report

Marketwired May 29, 2013

SumTotal Named a "Champion" in McLean & Company's Talent Management Suites Vendor Landscape Report

Business Wire May 23, 2013

Results from Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at Digestive Disease Week 2013

Business Wire May 21, 2013

Assessing Your Asthma is Key to Taking Control

PR Newswire May 13, 2013

Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients with Lipodystrophy During a 12-Month Period

Business Wire May 6, 2013

Today's Technical View on AstraZeneca, GlaxoSmithKline, PDL BioPharma, and Herbalife

PR Newswire April 1, 2013

AstraZeneca to Establish Strategic R&D Center in Gaithersburg, Md; Wilmington Remains North America Commercial Headquarters

Business Wire March 18, 2013

The Real Story Behind AZN, PPG, RHT and BA

Marketwired February 28, 2013

AstraZeneca Encourages Atherosclerosis Education among High Risk Patients during American Heart Month

PR Newswire February 14, 2013

AstraZeneca Recognized as a Top Company for Female Executives

Business Wire February 5, 2013